Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 14 points (0.1%) at 16,515 as of Thursday, April 24, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,645 issues advancing vs. 1,332 declining with 182 unchanged. The Energy industry currently sits up 0.3% versus the S&P 500, which is up 0.3%. On the negative front, top decliners within the industry include Williams Companies ( WMB), down 1.4%, Williams Partners ( WPZ), down 1.1%, Halliburton ( HAL), down 0.8% and China Petroleum & Chemical ( SNP), down 0.8%. Top gainers within the industry include Diamond Offshore Drilling ( DO), up 7.6%, Cabot Oil & Gas ( COG), up 4.5%, Devon Energy ( DVN), up 1.1%, Total ( TOT), up 1.0% and TransCanada ( TRP), up 1.0%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Core Laboratories ( CLB) is one of the companies pushing the Energy industry lower today. As of noon trading, Core Laboratories is down $20.66 (-9.7%) to $193.03 on heavy volume. Thus far, 826,695 shares of Core Laboratories exchanged hands as compared to its average daily volume of 304,500 shares. The stock has ranged in price between $192.20-$201.89 after having opened the day at $199.99 as compared to the previous trading day's close of $213.69. Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry in the Netherlands and internationally. The company operates in three segments: Reservoir Description, Production Enhancement, and Reservoir Management. Core Laboratories has a market cap of $9.6 billion and is part of the basic materials sector. Shares are up 11.9% year-to-date as of the close of trading on Wednesday. Currently there are 3 analysts that rate Core Laboratories a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates Core Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, impressive record of earnings per share growth and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Core Laboratories Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.